Skip to main content
Premium Trial:

Request an Annual Quote

Serologicals Wraps Up $74.8M LINCO Acquisition

NEW YORK, May 3 (GenomeWeb News) - Serologicals has completed its acquisition of LINCO, the company said today.


Serologicals disclosed its plan to buy it in March and said it would close last month.


Privately held LINCO comprises LINCO Research and LINCO Diagnostic Services. LRI sells multiplex, ELISA and RIA immunoassay products and technologies, and LDS provides bioanalytical contract services supporting research and drug development. The company is based in St. Louis.


As expected, Serologicals paid $64.5 million in cash for the stock of LINCO plus $10.3 million for the land and buildings the company occupies.


Last week, Millipore said it plans to pay $1.4 billion to acquire Serologicals.

The Scan

Two J&J Doses

Johnson & Johnson says two doses of its SARS-CoV-2 vaccine provides increased protection against symptomatic COVID-19, CNN reports.

Pfizer-BioNTech Vaccine Response in Kids

The Pfizer-BioNTech SARS-CoV-2 vaccine in a lower-dose format appears to generate an immune response among children, according to the Washington Post.

Chicken Changes to Prevent Disease

The Guardian writes that researchers are looking at gene editing chickens to help prevent future pandemics.

PNAS Papers on Siberian Dog Ancestry, Insect Reproduction, Hippocampal Neurogenesis

In PNAS this week: ancestry and admixture among Siberian dogs, hormone role in fruit fly reproduction, and more.